European Journal of Cancer
Volume 46, Issue 16 , Pages 3022-3036 , November 2010

Bevacizumab/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: A new paradigm for understanding the therapeutic effect of combined treatment

  • Cécile Ortholan

      Affiliations

    • University of Nice Sophia Antipolis, UMR CNRS 6543, Institute of Signalling, Developmental Biology and Cancer Research UMR CNRS 6543, France
    • ,
  • Jérôme Durivault

      Affiliations

    • University of Nice Sophia Antipolis, UMR CNRS 6543, Institute of Signalling, Developmental Biology and Cancer Research UMR CNRS 6543, France
    • ,
  • Jean-Michel Hannoun-Levi

      Affiliations

    • Centre Antoine Lacassagne, Department of Radiation Oncology, France
    • ,
  • Mélanie Guyot

      Affiliations

    • University of Nice Sophia Antipolis, UMR CNRS 6543, Institute of Signalling, Developmental Biology and Cancer Research UMR CNRS 6543, France
    • ,
  • Christine Bourcier

      Affiliations

    • University of Nice Sophia Antipolis, UMR CNRS 6543, Institute of Signalling, Developmental Biology and Cancer Research UMR CNRS 6543, France
    • ,
  • Damien Ambrosetti

      Affiliations

    • University of Nice Sophia Antipolis, Department of Anatomo-pathology, Pasteur Hospital Nice, France
    • ,
  • Stephen Safe

      Affiliations

    • Institute of Biosciences and Technology, Texas A&M University Health Science Centre, Houston, TX, USA
    • ,
  • Gilles Pagès

      Affiliations

    • University of Nice Sophia Antipolis, UMR CNRS 6543, Institute of Signalling, Developmental Biology and Cancer Research UMR CNRS 6543, France
    • Corresponding Author InformationCorresponding author: Tel.: +33 4 92 03 12 31; fax: +33 4 92 03 12 35.

Received 30 April 2010 ,Accepted 15 July 2010.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(10)00699-4

doi: 10.1016/j.ejca.2010.07.021

European Journal of Cancer
Volume 46, Issue 16 , Pages 3022-3036 , November 2010

Article Tools

* Image Usage & Resolution